GENOMMA LAB INTERNACIONAL ANNOUNCES EIGHTH DIVIDEND PAYMENT

Core Points - Genomma Lab Internacional, S.A.B. de C.V. has declared a cash dividend of $0.20 Mexican pesos per share, totaling $200 million pesos, payable to shareholders on June 21, 2024 [8] - The dividend per share represents a 2% increase compared to the previous quarter, attributed to the cancellation of 20 million shares approved at the last Annual General Shareholders Meeting (AGSM) [1][3] - The company intends to make dividend payments on a quarterly basis, subject to the terms established by the AGSM [4] Company Overview - Genomma Lab is one of the fastest-growing pharmaceutical and personal care products companies in Latin America, developing and marketing a wide range of premium branded products that are leaders in their respective categories [5] - The company operates a sound business model characterized by a unique combination of new product development, consumer-oriented marketing, a broad retail distribution network, and a low-cost, flexible supply chain [5] - Genomma Lab's shares are listed on the Mexican Stock Exchange under the ticker "LABB" [5]